Y RE -0.90 0.20 -0.60 -0.70 -0.50 0.50 Confidence limitb 4.955 ?0.021 10.02

Y RE -0.90 0.20 -0.60 -0.70 -0.50 0.50 Confidence limitb 4.955 ?0.021 10.02 ?0.078 14.91 ?0.173 4.965 ?0.026 9.95 ?0.09 20.10 ?0.231 PAR1 Antagonist Formulation Recovery 99.60 99.80 99.20 one hundred.60 99.40 99.Precision RSD a 0.51 0.75 1.02 0.40 0.68 0.Interday Accuracy RE -0.40 0.20 -0.80 0.60 -0.60 -0.Confidence limitb 4.98 ?0.025 9.98 ?0.075 14.88 ?0.152 five.03 ?0.020 9.94 ?0.068 19.92 ?0.abMean of six determinations; RSD : percentage relative standard deviation; RE : percentage relative error. Confidence limit at 95 self-confidence level and five degrees of freedom ( = 2.571).Journal of Analytical Methods in ChemistryJournal of Analytical Approaches in SIRT1 Modulator review ChemistryTable 5: Determination of GMF in its pharmaceutical dosage types applying the common addition method.Reagent Taken (g mL-1 ) Pure drug added (g mL-1 )2.BCG2.BCP2.BPB2.BTB5.MO4.0 8.0 12 2.0 6.0 10 four.0 8.0 12 4.0 eight.0 12 five.0 10Factive tablets Flobiotic tablet GemiQue tablets Total identified (g mL-1 ) Recovery a ?SD Total identified (g mL-1 ) Recovery ?SD Total located (g mL-1 ) Recovery ?SD 5.96 99.30 ?0.78 five.98 99.60 ?0.67 6.02 one hundred.30 ?0.51 9.91 99.10 ?1.02 10.02 100.20 ?0.82 9.92 99.20 ?0.70 13.97 99.80 ?1.24 13.96 99.70 ?1.09 13.99 99.90 ?0.94 3.996 99.90 ?0.66 3.96 99.10 ?0.42 3.97 99.30 ?0.38 eight.02 one hundred.20 ?0.90 7.98 99.80 ?0.69 7.99 99.90 ?0.84 11.92 99.30 ?0.95 12.05 one hundred.40 ?1.03 11.95 99.60 ?1.17 five.97 99.50 ?0.57 five.99 99.80 ?0.36 six.01 100.15 ?0.76 9.97 99.70 ?0.76 9.96 99.60 ?0.49 9.97 99.70 ?0.96 13.87 99.10 ?1.14 13.97 99.90 ?0.78 13.89 99.20 ?1.21 six.03 one hundred.50 ?0.48 six.01 100.10 ?0.53 six.01 one hundred.ten ?0.54 9.90 99.00 ?0.72 9.96 99.60 ?0.85 9.96 99.60 ?1.03 13.93 99.50 ?0.97 13.96 99.70 ?1.31 14.04 one hundred.30 ?1.15 9.97 99.70 ?0.32 9.91 99.10 ?0.70 9.99 99.90 ?0.65 14.94 99.60 ?0.56 15.06 100.40 ?1.05 14.97 99.80 ?0.85 24.95 99.80 ?0.90 24.88 99.50 ?1.25 24.90 99.60 ?1.aAverage of six determinations.Table six: Determination of MXF in its pharmaceutical dosage types applying the normal addition method.Reagent Taken (g mL-1 ) Pure drug added (g mL-1 )2.BCP2.BPB2.BTB5.MO2.0 six.0 10 4.0 8.0 12 two.0 4.0 8.0 5.0 10Avelox tablets Moxiflox tablets Moxifloxacin tablets Total discovered (g mL-1 ) Recovery a ?SD Total identified (g mL-1 ) Recovery ?SD Total discovered (g mL-1 ) Recovery ?SD three.98 99.40 ?0.56 3.96 99.ten ?0.62 three.98 99.60 ?0.48 7.98 99.70 ?0.83 eight.06 100.70 ?0.89 7.98 99.80 ?1.ten 11.89 99.ten ?1.20 12.02 100.20 ?1.26 11.92 99.30 ?1.17 five.98 99.60 ?0.61 five.97 99.50 ?0.35 five.96 99.30 ?0.36 9.99 99.90 ?0.84 9.96 99.60 ?0.60 9.99 99.90 ?0.63 14.07 one hundred.50 ?1.14 13.99 99.90 ?0.85 14.08 100.60 ?1.36 3.98 99.50 ?0.48 three.97 99.20 ?0.33 four.01 100.20 ?0.61 five.95 99.20 ?0.92 5.99 99.80 ?0.65 5.96 99.30 ?0.84 10.04 100.40 ?1.17 ten.01 one hundred.ten ?0.93 9.95 99.50 ?1.07 9.91 99.10 ?0.42 9.94 99.40 ?0.37 9.95 99.50 ?0.45 15.08 one hundred.50 ?0.76 15.03 one hundred.20 ?0.75 14.97 99.80 ?0.85 19.90 99.50 ?1.16 19.92 99.60 ?1.28 19.83 99.15 ?0.Journal of Analytical Methods in ChemistryaAverage of six determinations.Journal of Analytical Approaches in ChemistryTable 7: Determination of ENF in its pharmaceutical dosage forms applying the standard addition technique. ReagentTaken (g mL-1 ) Pure drug added (g mL-1 ) 5.0 BCG 5.0 BBTBa5.0 ten 15 5.0 10Enrocin 10 injectable Avitryl 20 injectable Total discovered (g mL-1 ) Recovery a ?SD Total discovered (g mL-1 ) Recovery ?SD 9.92 99.20 ?0.48 9.94 99.40 ?0.46 14.94 99.60 ?0.66 15.20 100.ten ?0.72 19.98 10.05 14.91 19.84 99.90 ?0.82 one hundred.50 ?0.56 99.40 ?0.83 99.20 ?1.20 19.90 9.97 15.05 19.82 99.50 ?1.05 99.70 ?0.52 one hundred.30 ?0.69 99.10 ?0.